Cholemax (Syrup) Instructions for Use

Marketing Authorization Holder

Marbiopharm, JSC (Russia)

ATC Code

A05AX (Other drugs for the treatment of biliary tract diseases)

Active Substance

Rosae fructus (State Pharmacopoeia)

Dosage Form

Cholemax

Syrup 40 g/100 g: 140 g or 300 g bottle.

Dosage Form, Packaging, and Composition

140 g – dark glass bottles (1) – cardboard packs.
300 g – dark glass bottles (1) – cardboard packs.

Clinical-Pharmacological Group

Herbal preparation with choleretic and spasmolytic action

Pharmacotherapeutic Group

Choleretic agent of plant origin

Pharmacological Action

Choleretic agent.

Indications

• Use for the treatment of non-calculous cholecystitis.
• Use for the treatment of hepatocholecystitis.

Administer to stimulate bile production and relieve spasms in the biliary tract associated with these conditions.

ICD codes

Dosage Regimen

Take orally, 30 minutes before meals.

For adults, administer 1 teaspoon (5 ml)2-3 times/day.

For children, administer 1/4 to 1/2 teaspoon 2-3 times/day.

Adhere to the prescribed frequency of administration to maintain consistent therapeutic effect.

Adverse Reactions

Monitor for gastrointestinal disturbances such as heartburn.

Be aware of potential for allergic reactions, including skin rash, itching, or urticaria.

Discontinue use and seek medical attention if severe adverse reactions occur.

Drug Interactions

Concurrent use with other choleretic agents may result in additive pharmacological effects.

Exercise caution when co-administering with drugs that have a narrow therapeutic index, as altered gastrointestinal motility may affect their absorption.

Consult a healthcare professional for potential interaction assessment before combining with other medications.

Contraindications

• Do not use in patients with known hypersensitivity to rose hips extract or any other component of the syrup.
• Do not administer to patients with cholelithiasis (gallstones) due to the risk of biliary colic.
• Avoid use in cases of obstruction of the biliary tract.

Screen patients for these conditions prior to initiating therapy.

Overdose

In case of significant overdose, expect intensified adverse reactions, particularly severe gastrointestinal discomfort.

Manage overdose with symptomatic and supportive care; there is no specific antidote.

Seek immediate medical attention or contact a poison control center in the event of ingestion of large quantities.

Pediatric Use

Use is possible according to the dosing regimen.

Special Precautions

Use with caution in patients with diabetes mellitus (the drug contains sugar).

Storage Conditions

Store at 2°C (36°F) to 25°C (77°F). Keep in original packaging, protected from light. Keep out of reach of children.

Dispensing Status

Over-the-Counter

Important Safety Information

This information is for educational purposes only and does not replace professional medical advice. Always consult your doctor before use. Dosage and side effects may vary. Use only as prescribed.